PT
Price T Rowe Associates Inc disclosed a 10.8% stake in PACB
Price T Rowe Associates Inc reported owning 10.8% of Pacific Biosciences Of California, Inc. (PACB) (33,445,993 shares) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G